SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001493152-24-006168
Filing Date
2024-02-13
Accepted
2024-02-13 17:00:42
Documents
2
Group Members
SB GLOBAL ADVISERS LTDSOFTBANK VISION FUND II-2 L.P.SVF II AGGREGATOR (JERSEY) L.P.SVF II AIV (DE) LLCSVF II HOLDINGS (DE) LLCSVF II INVESTMENT HOLDINGS (SUBCO) LLCSVF II INVESTMENT HOLDINGS LLC

Document Format Files

Seq Description Document Type Size
1 formsc13g.htm SC 13G 226010
2 ex99.htm EX-99 26656
  Complete submission text file 0001493152-24-006168.txt   254781
Mailing Address 1-7-1 KAIGAN MINATO-KU TOKYO M0 105-7537
Business Address 1-7-1 KAIGAN MINATO-KU TOKYO M0 105-7537 01181368892260
SOFTBANK GROUP CORP. (Filed by) CIK: 0001065521 (see all company filings)

IRS No.: 000000000
Type: SC 13G

Mailing Address 490 ARSENAL WAY, SUITE 200 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY, SUITE 200 WATERTOWN MA 02472 (857) 760-0900
Neumora Therapeutics, Inc. (Subject) CIK: 0001885522 (see all company filings)

IRS No.: 844367680 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-94162 | Film No.: 24627564
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)